A study to evaluate different strategies-(medicine, enhanced counselling, standard counselling) for stopping smoking in TB patients in TB program in India

EVALUATION OF DIFFERENT STRATEGIES (PHARMACOLOGIC INTERVENTION VERSUS ENHANCED MOTIVATION VS. STANDARD MOTIVATION) FOR SMOKING CESSATION IN TB PATIENTS UNDER TREATMENT IN THE RNTCP

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/07/003830

Enrollment

1200

Registered

2013-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pulmonary tuberculosis patients who are current smokers

Interventions

Intervention1: Bupropion SR 150 mg : Bupropion SR 150 mg tablet oral twice daily for 7 weeks will be given as a strategy for smoking cessation. Intervention2: Enhanced Counselling: Enhanced counsellin

Eligibility

Inclusion criteria

Inclusion criteria: Smear positive TB Current smokers

Exclusion criteria

Exclusion criteria: Seizure disorder Past psychiatric illness

Design outcomes

Primary

Measure	Time frame
Smoking CessationTimepoint: 2nd and 6th month	—

Secondary

Measure	Time frame
TB treatment CureTimepoint: 6th month	—

Countries

India

Contacts

Public ContactDr S Ramesh Kumar

National Institute for Research in Tuberculosis(ICMR)

drrameshskumar@yahoo.co.in9442119695

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026